| HELPFUL LINKS | |||||||||
 |
Monthly Calendar Topics |
|
Find A Hospital |
|
Find A Doctor | 
|
Medical Careers | ||
Alpha blockers stop and prevent cervical cancer in mice
The following information is provided by a third party and has not been edited by The Post and Courier for content or accuracy.
(Ivanhoe Newswire) -- Two FDA-approved drugs, one used to treat breast cancer and the other to treat osteoporosis, may eventually be used to stop cervical cancer in its tracks.
In a new study, researchers found two FDA-approved drugs -- fulvestrant and raloxifene, both drugs called ER alpha blockers -- eliminated cervical cancer in mice and cleared precancerous growths in the cervix and the vagina.
"We have begun to test whether the drugs are as effective in treating cervical cancer in human cells as they are in our mice," senior author Paul Lambert, of the McArdle Laboratory for Cancer Research and the UW-Madison Carbone Cancer Center, was quoted as saying.
Researchers used mice that were genetically engineered to carry human papilloma virus (HPV) 16. "Virtually all cervical cancers in women test positive for HPV 16," Lambert said.
Researchers tested the ER alpha blockers on HPV-positive mice with cervical cancer. After one month on the breast cancer drug fulvestrant, 11 of 13 mice lost all signs of the cancer. The osteoporosis drug raloxifene brought the same blocking effect. Both drugs prevented precancerous lesions from progressing to cancer.
The next step for researchers is to test the drugs on women's tissue samples after a cervical cancer surgery.
"We can't be sure how the science will translate from animals to humans, but we have faith in our mouse model," Lambert said. "There are many similarities in how cervical cancer develops and manifests itself in women and in mice."
SOURCE: Proceedings of the National Academy of Sciences, November 9, 2009
E-mail this story
Printer-friendly version
Comments
Use the comment form below to begin a discussion about this content.
Notice about comments:Postandcourier.com is pleased to offer readers the enhanced ability to comment on stories. We expect our readers to engage in lively, yet civil discourse. Postandcourier.com does not edit user submitted statements and we cannot promise that readers will not occasionally find offensive or inaccurate comments posted in the comments area. Responsibility for the statements posted lies with the person submitting the comment, not postandcourier.com. If you find a comment that is objectionable, please click "report abuse" and we will review it for possible removal. Please be reminded, however, that in accordance with our Terms of Use and federal law, we are under no obligation to remove any third party comments posted on our website.
Users can now build user-to-user connections, follow friends' recent posts, add an avatar that fits their personality, and more. If you have posted here before you'll need to sign up again, or if you've never posted before, start now by signing up!
Full terms and conditions can be read here.